Evidence map›Paper›PMID 33424794›Full record

ArticleFrontiers in microbiology2020

NGS-Based

David Dylus, Trestan Pillonel, Onya Opota, Daniel Wüthrich, Helena M B Seth-Smith, Adrian Egli, Stefano Leo, Vladimir Lazarevic, Jacques Schrenzel, Sacha Laurent and 13 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.2field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Deciphering the genetic context of the emerging OXA-484-producing carbapenem-resistant Escherichia coli from ST167 high-risk clone in the United Arab Emirates.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  4. Article
  5. Methicillin-resistantEmerging microbes & infections · 2022
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Transition From PCR-Ribotyping to Whole Genome Sequencing Based Typing ofFrontiers in cellular and infection microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 9 institutions in 2 countries.

David DylusDepartment of Computational Biology, University of Lausanne, Lausanne, Switzerland.
Trestan PillonelInstitute of Microbiology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Onya OpotaInstitute of Microbiology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Daniel WüthrichDivision of Clinical Bacteriology and Mycology, University Hospital of Basel, Basel, Switzerland.
Helena M B Seth-SmithDivision of Clinical Bacteriology and Mycology, University Hospital of Basel, Basel, Switzerland.
Adrian EgliDivision of Clinical Bacteriology and Mycology, University Hospital of Basel, Basel, Switzerland.
Stefano LeoBacteriology Laboratory, Division of Laboratory Medicine, Department of Genetics Laboratory Medicine and Pathology, Geneva University Hospitals, Geneva, Switzerland.
Vladimir LazarevicBacteriology Laboratory, Division of Laboratory Medicine, Department of Genetics Laboratory Medicine and Pathology, Geneva University Hospitals, Geneva, Switzerland.
Jacques SchrenzelBacteriology Laboratory, Division of Laboratory Medicine, Department of Genetics Laboratory Medicine and Pathology, Geneva University Hospitals, Geneva, Switzerland.
Sacha LaurentInstitute of Microbiology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Claire BertelliInstitute of Microbiology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Dominique S BlancService of Hospital Preventive Medicine, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Stefan NeuenschwanderInstitute for Infectious Diseases, University of Bern, Bern, Switzerland.
Alban RametteInstitute for Infectious Diseases, University of Bern, Bern, Switzerland.
Laurent FalquetSIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Frank ImkampInstitute of Medical Microbiology, University of Zurich, Zurich, Switzerland.
Peter M KellerInstitute of Medical Microbiology, University of Zurich, Zurich, Switzerland.
Andre KahlesSIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Simone OberhaensliSIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Valérie BarbiéSIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Christophe DessimozDepartment of Computational Biology, University of Lausanne, Lausanne, Switzerland.
Gilbert GreubInstitute of Microbiology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Aitana LebrandSIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
University of Lausanne · CHSIB Swiss Institute of Bioinformatics · CHUniversity Hospital of Geneva · CHUniversity of Bern · CHUniversity of Basel · CHUniversity of Zurich · CHETH Zurich · CHUniversity College London · GBUniversity Hospital of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Whole genome sequencing (WGS) enables high resolution typing of bacteria up to the single nucleotide polymorphism (SNP) level. WGS is used in clinical microbiology laboratories for infection control, molecular surveillance and outbreak analyses. Given the large palette of WGS reagents and bioinformatics tools, the Swiss clinical bacteriology community decided to conduct a ring trial (RT) to foster harmonization of NGS-based bacterial typing. The RT aimed at assessing methicillin-susceptible

Indexed as

bacterial typingEQAexternal quality assessmentnext generation sequencingNGSquality controlring trialSNP

Identifiers

PMID33424794
PMCPMC7793906
OpenAlexW3110056319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.